Targeting tau protein in Alzheimer's disease

Nov 16 - 2016 11:20 AM
Alzheimer's disease, the most common dementing illness, is a relentlessly progressive and fatal brain disorder that begins approximately 10–15 years before any symptoms manifest.
Read more

Regulators Tell Frontotemporal Dementia Community: We Play on Your Team

Apr 26 - 2016 10:52 AM
A meeting convened by the FTD Treatment Study Group offered an assembly of academic and industry scientists, funders, representatives of patient organizations, and caregivers the rare opportunity to collectively pick the brains of senior scientists from the Food and Drug Administration and the European Medicines Agency.
Read more

A 30-Year Quest For Alzheimer's Remedy Nears The Finish Line

Mar 18 - 2016 02:44 AM
After decades of researching a treatment for Alzheimer’s, Claude Wischik is set to find out whether his lonely 30-year battle can lead to one of the first real treatments for the memory-destroying brain disorder that afflicts millions worldwide.
Read more

Alzheimer’s Research Update

Mar 01 - 2016 03:52 AM
Alzheimer’s is at the forefront of brain research; 90% of what we know about Alzheimer’s has been discovered in the last 15 years. But while research has discovered much about this devastating disease, there is still much we don’t know.
Read more

Singapore's TauRx mulls Nasdaq IPO and sees a future for Alzheimer's treatment 

Jan 07 - 2016 04:03 AM
Singapore-based TauRx is expected to complete global Phase III trials this year for its Alzheimer's candidate, tau aggregation inhibitor LMTX, that will either start a new chapter in treatment or join a long list of flops.
Read more